Type:
Educational Exhibit
Keywords:
Performed at one institution, Observational, Retrospective, Cancer, Radiation therapy / Oncology, Radiation effects, Nuclear medicine conventional, Oncology, Nuclear medicine, Oncologic Imaging
Authors:
V. M. Rhodes1, T. Toma2; 1Southend/UK, 2SOUTHEND ON SEA/ESSEX/UK
DOI:
10.26044/ecr2020/C-00070
Conclusion
Results and Conclusion
The results of this retrospective study show that the prevalence of BAM in patients who have under gone pelvic radiotherapy treatment is as follows:
The results presented show that:
For Prostate Cancer 55% of patients had normal SeHCAT scan results and 45% of patients presented with BAM.
For Gynaecological Cancer 8% of patients had normal SeHCAT scan results and 92% of patients presented with BAM.
For Bowel Cancer patients 33% of patients had a normal SeHCAT scan result and 67% of patients presented with BAM.
This suggests that BAM is seen more frequently in gynaecological cancer patients than prostate patients in particular. This also suggests that nearly all (92%) of patients who underwent pelvic radiotherapy treatment suffered from BAM, implying that there may be a correlation between Gynaecological pelvic radiotherapy treatment and the occurrence of BAM in these patients. However there doesn’t seem to be any correlation between the site of the therapy and the severity of the BAM experienced.
These findings also suggest that there maybe a correlation between the size of the radiotherapy field used for treating gynaecological cancer and the high incidence of BAM comparing to the smaller fields used for treating prostate and colonic cancer.
However there doesn’t seem to be any correlation between the site of the therapy and the severity of the BAM experienced.